期刊文献+

^1H-MRS在颅内胶质瘤分级中的应用价值 被引量:12

The value of ^1H-MRS in cerebral glioma
暂未订购
导出
摘要 目的:探讨3.0T磁共振氢质子波谱(1H-MRS)相对定量分析对颅内胶质瘤术前分级的临床应用价值。方法:应用GE 3.0T磁共振系统,对32例经病理证实的胶质瘤患者进行1H-MRS检查,观察肿瘤实质区、瘤周水肿区及对侧正常区1H-MRS谱线表现,定量分析各种代谢物Cho/Cr、NAA/Cr、Cho/NAA、Cho/nCho、Lac/Cr比值变化,并与病理结果相对照。另设11例为正常对照组。结果:胶质瘤肿瘤实质区和正常对照组脑组织Cho/Cr、NAA/Cr、Cho/NAA(分别为2.10±1.04,0.84±0.44,2.05±0.70和0.87±0.13,1.43±0.14,0.61±0.10)存在显著性差异(P<0.05)。低、高级别胶质瘤肿瘤实质区Cho/Cr、NAA/Cr、Cho/NAA、Cho/nCho、Lac/Cr比值(分别为1.58±0.63,0.96±0.57,1.74±0.61,1.04±0.81,1.58±0.10和2.62±1.45,0.78±0.31,3.35±0.89,2.14±1.77,2.61±2.75)存在显著性差异(P<0.05)。低、高级别胶质瘤瘤周水肿区Cho/Cr、NAA/Cr、Cho/NAA、Cho/nCho比值(分别为1.43±0.32,0.82±0.45,1.22±0.19,1.23±0.36和2.21±0.49,1.12±0.23,2.09±0.82,1.47±1.13)亦存在显著性差异(P<0.05)。肿瘤实质区Cho/Cr、Cho/NAA、Cho/nCho、Lac/Cr比值与肿瘤的级别呈正相关(r=0.42,0.62,0.41,0.26),NAA/Cr与肿瘤级别呈负相关(r=-0.35),Cho/NAA与肿瘤级别的相关系数绝对值最大(r=0.62),相关性最高。结论:1H-MRS可为术前确定胶质瘤级别提供诊断依据,具有重要临床应用价值。 Objective: To approach the clinical application value of correspondance quantitative analysis with 3.0T magnetic resonance spectroscopy(1H-MRS) in grading cerebral glioma before operation.Methods: Thirty-two patients with cerebral glioma confirmed by pathological results were performed with 1H-MRS on GE 3.0T magnetic resonance system.The spectral line in the solid area of tumour,peritumor edematous area and normal-area of the opposite side were observed with 1H-MRS.Cho/Cr,NAA/Cr,Cho/NAA,Cho/nCho,Lac/Cr were analyzed.The results of 1H-MRS were compared with the results of pathology.Another 11 subjects were normal control.Results: There were significant differences in Cho/Cr,NAA/Cr,Cho/NAA between solid area of glioma and normal area of the opposite side(2.10±1.04,0.84±0.44,2.05±0.70 and 0.87±0.13,1.43±0.14,0.61±0.10 respectively).There were significant differences in Cho/Cr,NAA/Cr,Cho/NAA,Cho/nCho,Lac/Cr between solid area in the low grade glioma group and that in the high grade glioma group that is(1.58±0.63,0.96±0.57,1.74±0.61,1.04±0.81,1.58±0.10 and 2.62±1.45,0.78±0.31,3.35±0.89,2.14±1.77,2.61±2.75 respectively)(P0.05).There were also significant differences in Cho/Cr,NAA/Cr,Cho/NAA,Cho/nCho(i.e.1.43±0.32,0.82±0.45,1.22±0.19,1.23±0.36 and 2.21±0.49,1.12±0.23,2.09±0.82,1.47±1.13) between edematous area in the low grade glioma group and that in the high grade glioma group(P0.05).Cho/Cr,Cho/NAA,Cho/nCho,Lac/Cr(r=0.42,0.62,0.41,0.26) of solid area of tumor was of positive correlation with the grade of tumor,and NAA/Cr(r=-0.35) was of negative corretation.The correlative coefficient of Cho/NAA(r=0.62) was the maximum and had maximal dependability with grade of tumor.Conclusion: 1H-MRS had very important clinical application value in providing diagnostic support for grading of cerebral glioma before operation.
出处 《中国临床医学影像杂志》 CAS 北大核心 2011年第2期77-82,共6页 Journal of China Clinic Medical Imaging
关键词 神经胶质瘤 磁共振波谱学 Glioma Magnetic resonance spectroscopy
  • 相关文献

参考文献11

  • 1King AD,Yeung DK,Ahuja AT,et al.in vivo proton MR spectroscopy of primary and nodal nasopharyngeal carcinoma[J].AJNR,2004,25(3):484-490.
  • 2沈天真,张玉林,陈星荣.世界卫生组织脑肿瘤分类的进展[J].中国医学计算机成像杂志,2000,6(4):219-231. 被引量:141
  • 3Micknight TR.Proton magnetic resonance speetroscopie evaluation of brain tumor metabolism[J].Semin Oneol,2004,31 (5):605-617.
  • 4Sibtain NA,Hown FA,Saunders DE,et al.The clinical value of proton magnetic resonance spectroscopy in adult brain tumours[J].Clin Radiol,2007,62(2):109-119.
  • 5Oshiro S,Tsugu H,Komatsu F,et al.Quantitalive assessment of gliomas by proton magnetic resonance spectroscopy[J].Antieancer Res,2007,27(6A):3757-3763.
  • 6吴光耀,孙骏谟,田志雄,黄雄,张在鹏,谢长清.质子磁共振波谱在脑肿瘤中的应用研究[J].临床放射学杂志,2001,20(4):271-275. 被引量:18
  • 7Fountas KN,Kapsalaki EZ,Vogel RL,et al.Noninvasive histologic grading of solid astrocytomas using proton magnetic resonance spectrescopy[J].Stereotact Funct Neurosurg,2004,82(2-3):90-97.
  • 8Meknight TR,Bussche MH,Vigneron DB,et al.Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence[J].J Neurosurg,2002,97(4):794-802.
  • 9Kimura T,Sako K,Gotoh T,et al.In vlvo single-voxel proton Mr spectroscopy in brain lesions with ring-like enhancement[J].NMR Biomed,2001,14(6):339-347.
  • 10Likavcanova K,Dobrota D,Liptaj T,et al.In vitro study of astrocytic tumour metabolism by proton magnetic resonance spectroscopy[J] ,Gen Physiol Biophys,2005,24(3):327-335.

二级参考文献18

  • 1吴仁华,郎志谨.颅内肿瘤脑水肿的CT与病理对照研究[J].中华放射学杂志,1993,27(7):454-457. 被引量:18
  • 2李宏,Martin Hofmann,刘佳,江岩,郭丽,罗阳,鲁海欧.CD44v对大鼠多形胶质瘤细胞系RG2的转移促进作用[J].中华肿瘤杂志,1996,18(5):343-346. 被引量:11
  • 3[1]Bruhn H, Frahm J, Michael LG,et al. Noninvasive differentiation of tumors with use of localized H-1 spectroscopy in vivo: Initial experience in patients with cerebral tumors. Radiology, 1989, 172:541
  • 4[2]Robert D, Lai PH, Smith JS. Single voxel proton brain spectroscopy Exam (Probe/SV) in patients with primary brain tumors. AJR, 1996, 167:201
  • 5[3]Knock G, Mukherjisk L. Clinical application of proton MR spectroscopy. AJNR, 1996, 172:541
  • 6[4]Peptone H, Gupta RK, Roy R,et al. Characterization of intra-cranial man lesions with in vivo proton MR spectroscopy. AJNR, 1995, 16:1593
  • 7[5]Henny DJ, Ernst T. Human brain tumors assessment with in vivo proton MR spectroscopy. Radiology, 1993, 186:745
  • 8[6]Luyten PR, Marien AJH, Heindel W,et al. Metabolic imaging of patient with intra-cranial tumors: 1HMR spectroscopic imaging and PET. Radiology, 1990, 176:791
  • 9[7]Kugel H, Heindel W, Ernestus RI,et al. Human brain tumors: Spectral patterns detected with localized 1HMR spectroscopy. Radiology, 1992, 183:701
  • 10[8]Kugel AC, Donnelly SM, Halliday W,et al. Mobile lipids and metabolic heterogeneity of brain tumor as detectable by in vivo 1HMR spectroscopy. HMR Biomed, 1994, 7:172

共引文献170

同被引文献142

引证文献12

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部